Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 109 Pages
Report ld: 6317192
Request Sample
Customized Report
Microfluidic Chip in Biomedical Field Market Size(US$)

CAGR 2026-2032
9.8%
Market Size,2032
USD 11,060
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Microfluidic Chip in Biomedical Field market size was US$ 5806 million in 2025 and is forecast to reach a readjusted size of US$ 11060 million by 2032 with a CAGR of 9.8% during the forecast period 2026-2032.
Microfluidic chip in biomedical field is an integrated chip that integrates microscale channels and microfluidic technology, which is specially used in biomedical research, biological analysis and biological detection. In the biomedical field, microfluidic chips integrate or basically integrate the basic operating units such as sample preparation, reaction, separation, detection, cell culture, sorting, and lysis involved in fields such as chemistry and biology onto a chip of a few square centimeters or even smaller. A network is formed by microchannels, and controllable fluids run through the entire system to realize various functions of different laboratories such as conventional chemistry, biology, materials, and optics.
The global Microfluidic Chip in Biomedical Field market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Microfluidic Chip in Biomedical Field sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Microfluidic Chip in Biomedical Field manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Microfluidic Chip in Biomedical Field product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Microfluidic Chip in Biomedical Field value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Microfluidic Chip in Biomedical Field Product Scope
1.2 Microfluidic Chip in Biomedical Field by Type
1.2.1 Global Microfluidic Chip in Biomedical Field Sales by Type (2021, 2025 & 2032)
1.2.2 Silicon Material
1.2.3 Polymer Material
1.3 Microfluidic Chip in Biomedical Field by Application
1.3.1 Global Microfluidic Chip in Biomedical Field Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Disease Diagnosis
1.3.3 Drug Development
1.3.4 Cell Culture and Analysis
1.3.5 Other
1.4 Global Microfluidic Chip in Biomedical Field Market Estimates and Forecasts (2021-2032)
1.4.1 Global Microfluidic Chip in Biomedical Field Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Microfluidic Chip in Biomedical Field Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Microfluidic Chip in Biomedical Field Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Microfluidic Chip in Biomedical Field Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Microfluidic Chip in Biomedical Field Historical Market Scenario by Region (2021-2026)
2.2.1 Global Microfluidic Chip in Biomedical Field Sales Market Share by Region (2021-2026)
2.2.2 Global Microfluidic Chip in Biomedical Field Revenue Market Share by Region (2021-2026)
2.3 Global Microfluidic Chip in Biomedical Field Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Microfluidic Chip in Biomedical Field Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Microfluidic Chip in Biomedical Field Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Microfluidic Chip in Biomedical Field Market Size and Prospects (2021-2032)
2.4.2 Europe Microfluidic Chip in Biomedical Field Market Size and Prospects (2021-2032)
2.4.3 China Microfluidic Chip in Biomedical Field Market Size and Prospects (2021-2032)
2.4.4 Japan Microfluidic Chip in Biomedical Field Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Microfluidic Chip in Biomedical Field Historical Market Review by Type (2021-2026)
3.1.1 Global Microfluidic Chip in Biomedical Field Sales by Type (2021-2026)
3.1.2 Global Microfluidic Chip in Biomedical Field Revenue by Type (2021-2026)
3.1.3 Global Microfluidic Chip in Biomedical Field Average Price by Type (2021-2026)
3.2 Global Microfluidic Chip in Biomedical Field Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Microfluidic Chip in Biomedical Field Sales Forecast by Type (2027-2032)
3.2.2 Global Microfluidic Chip in Biomedical Field Revenue Forecast by Type (2027-2032)
3.2.3 Global Microfluidic Chip in Biomedical Field Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Microfluidic Chip in Biomedical Field
4 Global Market Size by Application
4.1 Global Microfluidic Chip in Biomedical Field Historical Market Review by Application (2021-2026)
4.1.1 Global Microfluidic Chip in Biomedical Field Sales by Application (2021-2026)
4.1.2 Global Microfluidic Chip in Biomedical Field Revenue by Application (2021-2026)
4.1.3 Global Microfluidic Chip in Biomedical Field Average Price by Application (2021-2026)
4.2 Global Microfluidic Chip in Biomedical Field Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Microfluidic Chip in Biomedical Field Sales Forecast by Application (2027-2032)
4.2.2 Global Microfluidic Chip in Biomedical Field Revenue Forecast by Application (2027-2032)
4.2.3 Global Microfluidic Chip in Biomedical Field Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Microfluidic Chip in Biomedical Field Applications
5 Competition Landscape by Players
5.1 Global Microfluidic Chip in Biomedical Field Sales by Player (2021-2026)
5.2 Global Top Microfluidic Chip in Biomedical Field Players by Revenue (2021-2026)
5.3 Global Microfluidic Chip in Biomedical Field Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Microfluidic Chip in Biomedical Field revenue as of 2025
5.4 Global Microfluidic Chip in Biomedical Field Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Microfluidic Chip in Biomedical Field, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Microfluidic Chip in Biomedical Field, Product Type & Application
5.7 Global Key Manufacturers of Microfluidic Chip in Biomedical Field, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Microfluidic Chip in Biomedical Field Sales by Company
6.1.1.1 North America Microfluidic Chip in Biomedical Field Sales by Company (2021-2026)
6.1.1.2 North America Microfluidic Chip in Biomedical Field Revenue by Company (2021-2026)
6.1.2 North America Microfluidic Chip in Biomedical Field Sales Breakdown by Type (2021-2026)
6.1.3 North America Microfluidic Chip in Biomedical Field Sales Breakdown by Application (2021-2026)
6.1.4 North America Microfluidic Chip in Biomedical Field Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Microfluidic Chip in Biomedical Field Sales by Company
6.2.1.1 Europe Microfluidic Chip in Biomedical Field Sales by Company (2021-2026)
6.2.1.2 Europe Microfluidic Chip in Biomedical Field Revenue by Company (2021-2026)
6.2.2 Europe Microfluidic Chip in Biomedical Field Sales Breakdown by Type (2021-2026)
6.2.3 Europe Microfluidic Chip in Biomedical Field Sales Breakdown by Application (2021-2026)
6.2.4 Europe Microfluidic Chip in Biomedical Field Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Microfluidic Chip in Biomedical Field Sales by Company
6.3.1.1 China Microfluidic Chip in Biomedical Field Sales by Company (2021-2026)
6.3.1.2 China Microfluidic Chip in Biomedical Field Revenue by Company (2021-2026)
6.3.2 China Microfluidic Chip in Biomedical Field Sales Breakdown by Type (2021-2026)
6.3.3 China Microfluidic Chip in Biomedical Field Sales Breakdown by Application (2021-2026)
6.3.4 China Microfluidic Chip in Biomedical Field Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Microfluidic Chip in Biomedical Field Sales by Company
6.4.1.1 Japan Microfluidic Chip in Biomedical Field Sales by Company (2021-2026)
6.4.1.2 Japan Microfluidic Chip in Biomedical Field Revenue by Company (2021-2026)
6.4.2 Japan Microfluidic Chip in Biomedical Field Sales Breakdown by Type (2021-2026)
6.4.3 Japan Microfluidic Chip in Biomedical Field Sales Breakdown by Application (2021-2026)
6.4.4 Japan Microfluidic Chip in Biomedical Field Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Information
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Agilent Technologies Microfluidic Chip in Biomedical Field Products Offered
7.1.5 Agilent Technologies Recent Development
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Information
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Thermo Fisher Scientific Microfluidic Chip in Biomedical Field Products Offered
7.2.5 Thermo Fisher Scientific Recent Development
7.3 Illumina
7.3.1 Illumina Company Information
7.3.2 Illumina Business Overview
7.3.3 Illumina Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Illumina Microfluidic Chip in Biomedical Field Products Offered
7.3.5 Illumina Recent Development
7.4 Dolomite Microfluidics
7.4.1 Dolomite Microfluidics Company Information
7.4.2 Dolomite Microfluidics Business Overview
7.4.3 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Dolomite Microfluidics Microfluidic Chip in Biomedical Field Products Offered
7.4.5 Dolomite Microfluidics Recent Development
7.5 Micronit
7.5.1 Micronit Company Information
7.5.2 Micronit Business Overview
7.5.3 Micronit Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Micronit Microfluidic Chip in Biomedical Field Products Offered
7.5.5 Micronit Recent Development
7.6 Bosch
7.6.1 Bosch Company Information
7.6.2 Bosch Business Overview
7.6.3 Bosch Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Bosch Microfluidic Chip in Biomedical Field Products Offered
7.6.5 Bosch Recent Development
7.7 microfluidic ChipShop
7.7.1 microfluidic ChipShop Company Information
7.7.2 microfluidic ChipShop Business Overview
7.7.3 microfluidic ChipShop Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.7.4 microfluidic ChipShop Microfluidic Chip in Biomedical Field Products Offered
7.7.5 microfluidic ChipShop Recent Development
7.8 Fluigent
7.8.1 Fluigent Company Information
7.8.2 Fluigent Business Overview
7.8.3 Fluigent Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Fluigent Microfluidic Chip in Biomedical Field Products Offered
7.8.5 Fluigent Recent Development
7.9 BioFluidix
7.9.1 BioFluidix Company Information
7.9.2 BioFluidix Business Overview
7.9.3 BioFluidix Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.9.4 BioFluidix Microfluidic Chip in Biomedical Field Products Offered
7.9.5 BioFluidix Recent Development
7.10 WenHao Microfluidic Technology
7.10.1 WenHao Microfluidic Technology Company Information
7.10.2 WenHao Microfluidic Technology Business Overview
7.10.3 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.10.4 WenHao Microfluidic Technology Microfluidic Chip in Biomedical Field Products Offered
7.10.5 WenHao Microfluidic Technology Recent Development
7.11 TinKer BioTechnology
7.11.1 TinKer BioTechnology Company Information
7.11.2 TinKer BioTechnology Business Overview
7.11.3 TinKer BioTechnology Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.11.4 TinKer BioTechnology Microfluidic Chip in Biomedical Field Products Offered
7.11.5 TinKer BioTechnology Recent Development
7.12 Dingxu Micro Control
7.12.1 Dingxu Micro Control Company Information
7.12.2 Dingxu Micro Control Business Overview
7.12.3 Dingxu Micro Control Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Dingxu Micro Control Microfluidic Chip in Biomedical Field Products Offered
7.12.5 Dingxu Micro Control Recent Development
7.13 Chongqing Chuangxin Biotechnology
7.13.1 Chongqing Chuangxin Biotechnology Company Information
7.13.2 Chongqing Chuangxin Biotechnology Business Overview
7.13.3 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Chongqing Chuangxin Biotechnology Microfluidic Chip in Biomedical Field Products Offered
7.13.5 Chongqing Chuangxin Biotechnology Recent Development
7.14 Shenzhen Mindray Bio-Medical Electronics
7.14.1 Shenzhen Mindray Bio-Medical Electronics Company Information
7.14.2 Shenzhen Mindray Bio-Medical Electronics Business Overview
7.14.3 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Shenzhen Mindray Bio-Medical Electronics Microfluidic Chip in Biomedical Field Products Offered
7.14.5 Shenzhen Mindray Bio-Medical Electronics Recent Development
7.15 Beijing Kerui Technology
7.15.1 Beijing Kerui Technology Company Information
7.15.2 Beijing Kerui Technology Business Overview
7.15.3 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Beijing Kerui Technology Microfluidic Chip in Biomedical Field Products Offered
7.15.5 Beijing Kerui Technology Recent Development
7.16 ThinXXS Microtechnology
7.16.1 ThinXXS Microtechnology Company Information
7.16.2 ThinXXS Microtechnology Business Overview
7.16.3 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.16.4 ThinXXS Microtechnology Microfluidic Chip in Biomedical Field Products Offered
7.16.5 ThinXXS Microtechnology Recent Development
7.17 Dolomite Bio
7.17.1 Dolomite Bio Company Information
7.17.2 Dolomite Bio Business Overview
7.17.3 Dolomite Bio Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Dolomite Bio Microfluidic Chip in Biomedical Field Products Offered
7.17.5 Dolomite Bio Recent Development
7.18 Elveflow
7.18.1 Elveflow Company Information
7.18.2 Elveflow Business Overview
7.18.3 Elveflow Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.18.4 Elveflow Microfluidic Chip in Biomedical Field Products Offered
7.18.5 Elveflow Recent Development
7.19 uFluidix
7.19.1 uFluidix Company Information
7.19.2 uFluidix Business Overview
7.19.3 uFluidix Microfluidic Chip in Biomedical Field Sales, Revenue and Gross Margin (2021-2026)
7.19.4 uFluidix Microfluidic Chip in Biomedical Field Products Offered
7.19.5 uFluidix Recent Development
8 Microfluidic Chip in Biomedical Field Manufacturing Cost Analysis
8.1 Microfluidic Chip in Biomedical Field Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Microfluidic Chip in Biomedical Field
8.4 Microfluidic Chip in Biomedical Field Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Microfluidic Chip in Biomedical Field Distributors List
9.3 Microfluidic Chip in Biomedical Field Customers
10 Microfluidic Chip in Biomedical Field Market Dynamics
10.1 Microfluidic Chip in Biomedical Field Industry Trends
10.2 Microfluidic Chip in Biomedical Field Market Drivers
10.3 Microfluidic Chip in Biomedical Field Market Challenges
10.4 Microfluidic Chip in Biomedical Field Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5806 million in 2025 to US$ 11060 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 180
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market was valued at US$ 5806 million in 2025 and is anticipated to reach US$ 11060 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 137
USD 2900.00
(Single User License)
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5806 million in 2025 and is projected to reach US$ 11060 million, growing at a CAGR of 9.8% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 133
USD 3950.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 10170 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 172
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market size was US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 105
USD 4250.00
(Single User License)
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 139
USD 3950.00
(Single User License)
The global market for Microfluidic Chip in Biomedical Field was valued at US$ 5335 million in the year 2024 and is projected to reach a revised size of US$ 10170 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field revenue was US$ 4860 million in 2023 and is forecast to a readjusted size of US$ 9344 million by 2030 with a CAGR of 9.8% during the review period (2024-2030).
Published Date: 2024-08-22
Pages: 160
USD 4350.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 9344 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Published Date: 2024-08-22
Pages: 184
USD 4900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market was valued at US$ 4860 million in 2023 and is anticipated to reach US$ 9344 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
Published Date: 2024-08-22
Pages: 103
USD 2900.00
(Single User License)
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5806 million in 2025 to US$ 11060 million by 2032, at a CAGR of 9.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 180
The global Microfluidic Chip in Biomedical Field market was valued at US$ 5806 million in 2025 and is anticipated to reach US$ 11060 million by 2032, at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 137
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5806 million in 2025 and is projected to reach US$ 11060 million, growing at a CAGR of 9.8% from 2026 to 2032.
Published: 2026-01-09
Pages: 133
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 10170 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 172
The global Microfluidic Chip in Biomedical Field market size was US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 105
The global market for Microfluidic Chip in Biomedical Field was estimated to be worth US$ 5335 million in 2024 and is forecast to a readjusted size of US$ 10170 million by 2031 with a CAGR of 9.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 139
The global market for Microfluidic Chip in Biomedical Field was valued at US$ 5335 million in the year 2024 and is projected to reach a revised size of US$ 10170 million by 2031, growing at a CAGR of 9.8% during the forecast period.
Published: 2025-03-10
Pages: 99
The global Microfluidic Chip in Biomedical Field revenue was US$ 4860 million in 2023 and is forecast to a readjusted size of US$ 9344 million by 2030 with a CAGR of 9.8% during the review period (2024-2030).
Published: 2024-08-22
Pages: 160
The global Microfluidic Chip in Biomedical Field market is projected to grow from US$ 5335 million in 2024 to US$ 9344 million by 2030, at a Compound Annual Growth Rate (CAGR) of 9.8% during the forecast period.
Published: 2024-08-22
Pages: 184
The global Microfluidic Chip in Biomedical Field market was valued at US$ 4860 million in 2023 and is anticipated to reach US$ 9344 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.
Published: 2024-08-22
Pages: 103
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now